ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 42 filers reported holding ALEXZA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.04 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $122,000 | +13.0% | 98,914 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $108,000 | -47.3% | 98,914 | 0.0% | 0.02% | -17.9% |
| Q1 2015 | $205,000 | +39.5% | 98,914 | 0.0% | 0.03% | -28.2% |
| Q4 2014 | $147,000 | -36.1% | 98,914 | 0.0% | 0.04% | -23.5% |
| Q3 2014 | $230,000 | -49.1% | 98,914 | 0.0% | 0.05% | -32.9% |
| Q2 2014 | $452,000 | +3.2% | 98,914 | 0.0% | 0.08% | +22.6% |
| Q1 2014 | $438,000 | -6.4% | 98,914 | 0.0% | 0.06% | -12.7% |
| Q4 2013 | $468,000 | -7.5% | 98,914 | 0.0% | 0.07% | -9.0% |
| Q3 2013 | $506,000 | +17.9% | 98,914 | 0.0% | 0.08% | -44.7% |
| Q2 2013 | $429,000 | – | 98,914 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,212,555 | $5,262,000 | 100.00% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $429,000 | 0.14% |
| Rotella Capital Management, Inc. | 10,000 | $43,000 | 0.14% |
| BBT Capital Management, LLC | 132,533 | $575,000 | 0.03% |
| Jefferies Group LLC | 477,500 | $2,072,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 246,473 | $1,070,000 | 0.02% |
| LANSDOWNE PARTNERS LIMITED PARTNERSHIP | 307,500 | $1,335,000 | 0.02% |
| FEDERATED HERMES, INC. | 674,300 | $2,926,000 | 0.01% |
| KNIGHT CAPITAL GROUP LLC | 61,466 | $265,000 | 0.01% |
| CREDIT SUISSE AG/ | 654,292 | $2,839,000 | 0.00% |